Serina Therapeutics, Inc.
SER
$5.70
-$0.15-2.56%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -360.70% | -19.52% | -146.29% | -669.18% | 275.64% |
| Total Depreciation and Amortization | 833.33% | 3.70% | 235.29% | 92.31% | -63.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -153.79% | -93.63% | -79.15% | 367.68% | -832.07% |
| Change in Net Operating Assets | 31.20% | 1,913.46% | -4,657.14% | 151.08% | -22.91% |
| Cash from Operations | -3,892.56% | -189.26% | -826.97% | -122.43% | 114.08% |
| Capital Expenditure | 92.86% | 97.48% | 100.00% | -- | -621.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.86% | 97.48% | 100.00% | -- | -621.65% |
| Total Debt Issued | -- | -- | -- | -76.24% | -100.00% |
| Total Debt Repaid | 92.31% | 33.33% | -1,116.67% | -18.18% | 99.64% |
| Issuance of Common Stock | -- | 514.29% | 498,700.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 38,800.00% | 4,200.00% | 48,890.91% | -72.96% | -113.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,050.00% | -152.32% | -122.02% | -87.88% | 104.90% |